Van Strum & Towne’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.57M Sell
6,051
-408
-6% -$414K 1.62% 23
2025
Q4
$6.94M Sell
6,459
-320
-5% -$306K 1.94% 17
2025
Q3
$5.17M Sell
6,779
-250
-4% -$186K 1.52% 24
2025
Q2
$5.48M Sell
7,029
-150
-2% -$117K 1.73% 20
2025
Q1
$5.93M Buy
7,179
+1,300
+22% +$1.08M 1.99% 17
2024
Q4
$4.54M Buy
5,879
+1,204
+26% +$997K 1.6% 23
2024
Q3
$4.14M Sell
4,675
-600
-11% -$539K 1.43% 25
2024
Q2
$4.78M Sell
5,275
-200
-4% -$160K 1.73% 21
2024
Q1
$4.26M Hold
5,475
1.56% 22
2023
Q4
$3.19M Hold
5,475
1.25% 26
2023
Q3
$2.94M Hold
5,475
1.24% 24
2023
Q2
$2.57M Hold
5,475
1.06% 27
2023
Q1
$1.88M Hold
5,475
0.8% 33
2022
Q4
$2M Buy
5,475
+75
+1% +$26.6K 0.86% 33
2022
Q3
$1.75M Hold
5,400
0.81% 33
2022
Q2
$1.75M Hold
5,400
0.75% 32
2022
Q1
$1.55M Hold
5,400
0.58% 39
2021
Q4
$1.49M Hold
5,400
0.54% 38
2021
Q3
$1.25M Hold
5,400
0.49% 42
2021
Q2
$1.24M Hold
5,400
0.59% 35
2021
Q1
$1.01M Hold
5,400
0.51% 38
2020
Q4
$912K Buy
+5,400
New +$806K 0.51% 37

Other funds holding LLY

Van Strum & Towne's LLY Position: Q1 2026 in Review

Van Strum & Towne reduced its Eli Lilly (LLY) stake by 6.3% in Q1 2026, selling an estimated $414K and leaving 6,051 shares worth $5.57M. The position accounts for 1.62% of the portfolio, ranked #23.

Van Strum & Towne first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $6.94M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Van Strum & Towne held 6,051 shares of Eli Lilly worth $5.57M as of Q1 2026.
  • Van Strum & Towne sold 408 Eli Lilly shares in Q1 2026, an estimated $414K.
  • Eli Lilly made up 1.62% of Van Strum & Towne's portfolio in Q1 2026, its #23 holding.
  • Van Strum & Towne first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
  • Van Strum & Towne's Eli Lilly position peaked at $6.94M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Van Strum & Towne's 13F filing for Q1 2026, filed 7 May 2026.